Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1999 | 06-1999 | 03-1999 | 12-1998 | 09-1998 | |
| Sales | 12,536 | 7,170 | 6,918 | 9,182 | 12,566 |
| Cost of Goods | 1,030 | 0 | 0 | 1,630 | 1,280 |
| Gross Profit | 11,500 | 7,170 | 6,910 | 7,570 | 11,280 |
| Operating Expenses | 15,410 | 14,310 | 14,780 | 12,710 | 12,170 |
| Operating Income | -3,874 | -7,140 | -7,862 | -4,528 | -604 |
| Interest Expense | 70 | 80 | 80 | 100 | 100 |
| Other Income | -976 | -610 | -988 | -922 | -686 |
| Pre-tax Income | -4,920 | -7,830 | -8,930 | -5,550 | -1,390 |
| Net Income Continuous | -4,925 | -7,833 | -8,930 | -5,541 | -1,395 |
| Net Income | $-4,925 | $-7,833 | $-8,930 | $-5,541 | $-1,395 |
| EPS Basic Total Ops | -0.16 | -0.25 | -0.29 | -0.18 | -0.04 |
| EPS Basic Continuous Ops | -0.16 | -0.25 | -0.29 | -0.18 | -0.05 |
| EPS Diluted Total Ops | -0.16 | -0.25 | -0.29 | -0.18 | -0.04 |
| EPS Diluted Continuous Ops | -0.16 | -0.25 | -0.29 | -0.18 | -0.05 |
| EBITDA(a) | $-2,974 | $-6,310 | $-7,142 | $-3,848 | $86 |